Alembic Pharmaceuticals Limited

NSE APLLTD.NS

Alembic Pharmaceuticals Limited Goodwill for the year ending March 31, 2024: USD 0.00

Alembic Pharmaceuticals Limited Goodwill is USD 0.00 for the year ending March 31, 2024, a 0.00% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.

Alembic Pharmaceuticals Limited Goodwill for the year ending March 31, 2023 was USD 0.00, a 0.00% change year over year.
Alembic Pharmaceuticals Limited Goodwill for the year ending March 31, 2022 was USD 0.00, a 0.00% change year over year.
Alembic Pharmaceuticals Limited Goodwill for the year ending March 31, 2021 was USD 0.00, a 0.00% change year over year.
Alembic Pharmaceuticals Limited Goodwill for the year ending March 31, 2020 was USD 0.00, a -100.00% change year over year.

Key data

Date	Goodwill	Total Assets	Current Liabilities	Total Non-Current Liabilities

NSE: APLLTD.NS

Alembic Pharmaceuticals Limited

CEO	Mr. Chirayu Ramanbhai Amin
IPO Date	Sept. 20, 2011
Location	India
Headquarters	Alembic Road
Employees	14,858
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies Eyewear Personal Care

Description

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations. The company also provides branded and generic formulations in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, and anti-diabetic. In addition, it exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.

Key trends

Past 5 years